CHAPTER 17. Antidiabetic Drugs and Cardiovascular Risk: Where Do We Stand?

Kapitel in diesem Buch

1. Frontmatter i
2. Contents v
3. Contributors ix
4. The Concept of Iatrogenicity 1
5. PART I. Medical Harm
6. CHAPTER 1. Iatrogenicity: Definition, History, and Modern Context 5
7. CHAPTER 2. Epidemiology and Public Health Aspects and Implications of Iatrogenicity: Regulatory, Legal and Ethical Dimensions 16
8. CHAPTER 3. Risk Management: The Medical Center Administration Perspective 22
9. CHAPTER 4. Iatrogenicity from the Patient’s Perspective 28
10. CHAPTER 5. A Naturopathic Perspective on Iatrogenesis 34
11. PART II. Iatrogenicity of Cardiovascular Drugs and Cardiovascular Toxicity of Noncardiac Drugs
12. CHAPTER 6. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes 47
13. CHAPTER 7. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death 62
14. CHAPTER 8. Chemotherapy-Induced Cardiomyopathy 77
15. CHAPTER 9. Iatrogenicity of Blood Pressure Measurement in the Diagnosis of Hypertension 88
16. CHAPTER 10. Antihypertensive Drug–Induced Iatrogenic Cardiovascular Syndromes 101
17. CHAPTER 11. Iatrogenicity of Cardiovascular Drugs Associated With Cardiac and Noncardiac Toxicities: Antihypertensive Agents and Biologics 116
18. CHAPTER 12. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia 143
19. CHAPTER 13 Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect 156
20. CHAPTER 14. Iatrogenic Aspects of Lipid-Lowering, Antiplatelet, and Anticoagulant Agents 163
21. CHAPTER 15. Iatrogenic Effects of Urologic Drugs on the Cardiovascular System 175
22. CHAPTER 16. Iatrogenicity and Antianginal Drugs 188
23. CHAPTER 17. Antidiabetic Drugs and Cardiovascular Risk: Where Do We Stand? 194
24. CHAPTER 18. Cardiovascular Iatrogenicity in Older Adults 205
25. PART III. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries
26. CHAPTER 19. Iatrogenic Aspects of Noninvasive and Invasive Diagnostic Methods in Interventional Cardiology 221
27. CHAPTER 20. Iatrogenicity Associated With Interventional Treatment Modalities in Cardiology 233
28. CHAPTER 21. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries 243
29. CHAPTER 22. Iatrogenic Aspects of Cardiac Electrophysiology 255
30. CHAPTER 23. Iatrogenic Aspects in Cardiac Device 271
31. CHAPTER 24. Cardiovascular Iatrogenicity of Respiratory Therapeutic Modalities 287
32. PART IV. Iatrogenic Aspects of Sport Cardiology and Lifestyle Modifications
33. CHAPTER 25. Trained Athletes 309
34. CHAPTER 26. Sports Cardiology 318
35. CHAPTER 27. Dangers of Lifestyle Modification Advice 327
36. PART V. Iatrogenicity of Dietary Supplements, Herbal Products, and Other Nontraditional Therapies in Cardiovascular Medicine
37. CHAPTER 28. Safety of Dietary and Herbal Supplements: Side Effects and Contraindications 337
38. CHAPTER 29. Interactions Between Supplements and Medications 370
39. Index 415